Systemic Synuclein Sampling Study (S4)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lana Chahine, MD
University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Toronto Western Hospital Movement Disorders Centre
Toronto, Ontario, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mayo Clinic Arizona
Scottsdale, Arizona, United States
- Institute for Neurodegenerative Disorders
New Haven, Connecticut, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2015
- Primary completion
- 1 Aug 2017
- Completion
- 1 Aug 2017
- Last update posted
- 17 Aug 2017
- Registered enrollment
- 80
- Registry id
- NCT02572713
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.